Women With Certain Types Of Migraines Have Higher Risk Of Heart Disease
Study Authors Did Not Report Financial Ties
The six authors of the study did not disclose to JAMA that they have consulted for, or received research funds from, pharmaceutical companies that manufacture treatments for heart disease or migraines, the AP/Miami Herald reports. JAMA in January implemented a policy that requires financial disclosures from researchers before acceptance of studies for publication, and an editorial published in the journal last week indicated that “JAMA was getting tougher as a result of … recent breaches” of the policy, the AP/Herald reports. JAMA Editor in Chief Catherine DeAngelis said that journal editors were not aware of the financial ties until the Associated Press informed her about them last week. The authors said they did not report the financial ties because the study does not promote a treatment. JAMA on Tuesday published online a letter from the authors of the study to explain their failure to disclose the financial ties, as well as a response from DeAngelis and a correction. DeAngelis said that the letter, her response and the correction will appear in a future print edition of JAMA. “Let me decide what’s pertinent or not,” DeAngelis said, adding, “Authors should always err on the side of full disclosure.” Kurth in an interview said that the financial ties “do not represent a conflict of interest” (Tanner, AP/Miami Herald, 7/19).